Paid Clinical Trials in Austria

Paid Clinical Trials and Focus Groups

Find Paid Clinical Trials

Paid Clinical Trials in Austria

Top of Directory » All Locations » More Countries » Austria


  • Primary Operation in SYnchronous meTastasized InVasivE Breast Cancer

    Conditions:   Synchronous Metastasized Breast Cancer;   Circulating Tumor Cells
    Interventions:   Procedure: Surgery;   Procedure: Surgery on Demand
    Sponsor:   Austrian Breast & Colorectal Cancer Study Group
    Not yet recruiting - verified November 2009

  • Banded Versus Conventional Laparoscopic Roux-en-Y (GABY)

    Condition:   Morbid Obesity Requiring Bariatric Surgery
    Interventions:   Procedure: Conventional laparoscopic Roux-en-Y gastric bypass;   Procedure: conventional laparoscopic Roux-en-Y gastric bypass with additional restrictive silastic ring
    Sponsor:   ClinTrio Ltd.
    Recruiting - verified November 2009

  • The Effect of High-dose Remifentanil on Established Sunburn-induced Hyperalgesia in Human Volunteers (HighDose RemiSun)

    Condition:   Hyperalgesia
    Interventions:   Drug: Remifentanil;   Drug: Midazolam
    Sponsor:   Medical University of Vienna
    Recruiting - verified November 2009

  • Safety and Tolerability of Chitosan-N-acetylcysteine Eye Drops in Healthy Young Volunteers

    Condition:   Dry Eye Syndroms
    Intervention:   Device: Chitosan- N- Acetylcysteine eye drops
    Sponsor:   Medical University of Vienna
    Not yet recruiting - verified November 2009

  • Single-arm Study of Photodynamic Laser Therapy Using Foscan for Non-curatively-resectable Bile Duct Carcinoma

    Condition:   Non-curative Resectable Bile Duct Carcinoma
    Intervention:   Drug: Temoporfin
    Sponsors:   University of Salzburg;   Biolitec Pharma ltd., United Drug House, Magna Drive,Dublin 24,Irland
    Recruiting - verified November 2009

  • A Study of the Safety and Efficacy of 4 Doses of BI 1744 CL Delivered Via the Respimat in Patients With Asthma.

    Condition:   Asthma
    Interventions:   Drug: BI 1744 CL;   Drug: Placebo;   Drug: Respimat
    Sponsor:   Boehringer Ingelheim Pharmaceuticals
    Not yet recruiting - verified November 2009

  • An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

    Condition:   Hepatitis B, Chronic
    Intervention:  
    Sponsor:   Hoffmann-La Roche
    Recruiting - verified November 2009

  • Phase 3b Study to Evaluate Advagraf in Combination With Mycophenolate Mofetil and Basiliximab in Liver Transplantation

    Condition:   Liver Transplantation
    Interventions:   Drug: Advagraf;   Drug: Mycophenolate Mofetil;   Drug: Basiliximab;   Drug: Corticosteroids
    Sponsor:   Astellas Pharma Inc
    Recruiting - verified November 2009

  • BIBF 1120 or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer

    Conditions:   Ovarian Neoplasms;   Peritoneal Neoplasms
    Interventions:   Drug: BIBF 1120;   Drug: Placebo
    Sponsor:   Boehringer Ingelheim Pharmaceuticals
    Not yet recruiting - verified November 2009

  • A Study of RO5072759 With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia

    Condition:   Lymphocytic Leukemia, Chronic
    Interventions:   Drug: RO5072759;   Drug: rituximab;   Drug: chlorambucil
    Sponsors:   Hoffmann-La Roche;   Genentech
    Not yet recruiting - verified November 2009

  • An Open Label Safety and Tolerability Study of AIN457 in Patients With Moderate to Severe Crohn's Disease

    Conditions:   Crohn's Disease;   Inflammatory Bowel Disease
    Intervention:   Drug: AIN457
    Sponsor:   Novartis Pharmaceuticals
    Enrolling by invitation - verified November 2009

  • A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis

    Condition:   Rheumatoid Arthritis
    Interventions:   Drug: tocilizumab;   Drug: tocilizumab;   Drug: methotrexate
    Sponsor:   Hoffmann-La Roche
    Recruiting - verified November 2009

  • Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)

    Condition:   Retinal Vein Occlusion
    Interventions:   Drug: VEGF Trap-Eye (BAY86-5321);   Other: Sham treatment
    Sponsors:   Bayer;   Regeneron Pharmaceuticals
    Recruiting - verified November 2009

  • Comparison of the I-gel Laryngeal Mask and the Classic Laryngeal Mask in Patients With a BMI > 25 During Elective Surgery

    Conditions:   Surgery;   Intubation
    Intervention:   Device: I-gel laryngeal mask, classic laryngeal mask
    Sponsor:   Medical University of Vienna
    Recruiting - verified October 2009

  • Comparison of Hypoglycaemic Response Between NN1250 and Insulin Glargine in Type 1 Diabetics

    Condition:   Diabetes Mellitus, Type 1
    Interventions:   Drug: NN1250;   Drug: insulin glargine
    Sponsor:   Novo Nordisk
    Recruiting - verified November 2009

    • Menu
    Find Paid Clinical Trials